Company Information

  

Address: SOUTH COUNTY BUSINESS PARK
LEOPARDSTOWN 
City: DUBLIN 18 
State:  
Zip Code: 00000 
Telephone: 00 353 1 291 2000 

Description of Business

Primary SIC Code: 8731
(As filed with the SEC)  

ICON public limited company ("ICON plc") is a clinical research organization ("CRO"), founded in 1990, which provides outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/20175.13NA21.86
12/20153.97NA19.57
09/20142.54NA22.53
06/20142.08NA22.65
03/20141.91NA24.90
12/20131.65NA24.49
09/20131.49NA27.47
06/20131.35NA26.24

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity0.58Total Liab/Total Assets0.45
Net Inc/Total Assets0.13Total Liab/Inv Cap0.60
Net Inc/Inv Cap0.18Total Liab/Comm Equity1.97
Pretax Inc/Net Sales0.19Interest Coverage Ratio26.98
Net Inc/Net Sales0.16Curr Debt/EquityNA
Cash Flow/Net Sales0.22LTD/Equity0.29
SG&A/NetSales0.18Total Debt/Equity0.29
Asset Utilization   Liquidity  
Net Receivables Turnover2.57Quick Ratio1.95
Inventory TurnoverNACurrent Ratio1.95
Inventory Day SalesNANet Rec/Curr Assets0.64
Net Sales/Work Cap3.29Inv/Curr AssetsNA
Net Sales/PP&E10.78  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) 1,758.44 1,666.49 1,574.98 1,503.32
Cost of Goods Sold 1,027.31 961.33 908.98 903.17
Selling & Admin Exps 323.74 325.73 326.79 336.46
Operating Income 338.34 311.69 281.54 202.35
Interest Exp 12.63 13.01 3.99 0.79
Pretax Income 328.06 300.17 278.85 202.72
Other Income 2.35 1.48 1.31 1.15
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 281.49 262.18 239.54 172.47

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 360.45 260.59 189.90 216.00
Receivables - Total 706.19 662.20 636.71 575.04
Inventories - Total NA NA NA NA
Total Current Assets 1,101.02 957.96 862.74 819.51
Net Property, Plant & Equipment 163.05 148.97 150.22 148.19
Total Assets 2,146.62 1,825.84 1,717.21 1,528.85
Liabilities        
Accounts Payable 332.56 303.68 339.92 287.27
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 566.06 494.41 571.80 538.36
Long-Term Debt 348.89 348.51 348.31 0.00
Total Liabilities 955.62 880.67 954.11 578.64
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 4.66 4.69 4.68 5.04
Retained Earnings 742.80 587.85 435.94 655.19
Treasury Stock NA NA NA NA
Total Stockholders' Equity 1,191.00 945.17 763.10 950.21
Total Liabilities and Stockholders' Equity 2,146.62 1,825.84 1,717.21 1,528.85

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities 383.08 259.20 279.07 169.04
Net Cash Provided by Investing Activities -177.81 -74.81 -204.31 -111.41
Net Cash Provided by Financing Activities -119.28 -93.71 -81.39 -116.40

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20131,336.06102.811.65
12/20141,503.32172.47--
12/20151,574.98239.543.97
12/20161,666.49262.18--
12/20171,758.44281.495.13
Growth Rates7.1128.63--

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1836949,13590.44




Report Date : 9/17/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.